Regional specific microglia activation to different doses of LPS in C57BL6 mice. (A) Percentage of marked area by Iba1 in vehicles (white columns), LPS treated mice with 0.005 mg/kg (clear gray columns), 0.05 mg/kg (medium gray columns), 0,5 mg/kg (dark gray columns), 5 mg/kg (black columns). Two-way ANOVA. FBrain Regions (15, 160) = 57.94, p < 0.0001. FTreatment (4, 160) = 188,3, p < 0.0001. FInteraction (60, 160) = 1.599, p < 0.0110, and n = 3 mice per region. Significance: respect relative vehicles. (B) Iba1 positive cell density mm2. Same column color as graph (A). Two-way ANOVA. FBrain Regions (15, 160) = 112.7, p < 0.0001. FTreatment (4, 160) = 222.1, p < 0.0001. FInteraction (60, 160) = 2.039, p < 0.0002, and n = 3 mice per region. Significance: (*) Significance: respect relative vehicles. (C) Relative changes in percentage of area marked by Iba1. Same column color as graph (A). Two-way. FBrain Regions (15, 160) = 4.169, p < 0.0001. FTreatment (4, 160) = 202.4, p < 0.0001. FInteraction (60, 160) = 1.259, p < 0.1304, and n = 3 mice per region. Significance: (*) respect relative vehicles. (D) Relative changes in Iba1 positive cell density. Same column color as graph (A). Two-way ANOVA. FBrain Regions (15, 160) = 5.660, p < 0.0001. FTreatment (4, 160) = 247.6, p < 0.0001. FInteraction (60, 160) = 1.848, p < 0.0013, and n = 3 mice per region. Significance: (*) respect relative vehicles. (E) Representative images of Iba 1 staining in Veh, 0.05 and 5 mg/kg LPS doses in NAc, striatum, PSM cortex and cerebellum. Scale bars = 50 um in (E) and 10 um insets.